INNOVIVA, INC. Investment Income, Net
INNOVIVA, INC. (INVA) reported Investment Income, Net of $453.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-10-27.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2021-10-27
- INNOVIVA, INC. investment income, net for the quarter ending 2021-09-30 was $453.00K, a 1004.88% increase year-over-year.
- INNOVIVA, INC. investment income, net for the quarter ending 2021-06-30 was $20.00K, a 87.34% decline year-over-year.
- INNOVIVA, INC. investment income, net for the quarter ending 2021-03-31 was $30.00K, a 97.70% decline year-over-year.
- INNOVIVA, INC. investment income, net for the quarter ending 2020-12-31 was $23.00K, a 98.50% decline year-over-year.
- INNOVIVA, INC. investment income, net for fiscal 2020 was $1.52M, a 72.49% decline from fiscal 2019.
- INNOVIVA, INC. investment income, net for fiscal 2019 was $5.54M, a 233.73% increase from fiscal 2018.
- INNOVIVA, INC. investment income, net for fiscal 2018 was $1.66M, a 26.62% increase from fiscal 2017.
- INNOVIVA, INC. investment income, net for fiscal 2017 was $1.31M, a 125.26% increase from fiscal 2016.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2021-09-30 | $453.00K 10-Q · filed 2021-10-27 | $473.00K derived: sum of 2 quarters · filed 2021-10-27 | $503.00K 10-Q · filed 2021-10-27 | $526.00K derived: sum of 4 quarters · filed 2021-10-27 |
| 2021-06-30 | $20.00K 10-Q · filed 2021-07-29 | $50.00K 10-Q · filed 2021-07-29 | $73.00K derived: sum of 3 quarters · filed 2021-07-29 | $114.00K derived: sum of 4 quarters · filed 2021-10-27 |
| 2021-03-31 | $30.00K 10-Q · filed 2021-04-28 | $53.00K derived: sum of 2 quarters · filed 2021-04-28 | $94.00K derived: sum of 3 quarters · filed 2021-10-27 | $252.00K derived: sum of 4 quarters · filed 2021-10-27 |
| 2020-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $64.00K derived: sum of 2 quarters · filed 2021-10-27 | $222.00K derived: sum of 3 quarters · filed 2021-10-27 | $1.52M 10-K · filed 2021-02-25 |
| 2020-09-30 | $41.00K 10-Q · filed 2021-10-27 | $199.00K derived: sum of 2 quarters · filed 2021-10-27 | $1.50M 10-Q · filed 2021-10-27 | $3.04M derived: sum of 4 quarters · filed 2021-10-27 |
| 2020-06-30 | $158.00K 10-Q · filed 2021-07-29 | $1.46M 10-Q · filed 2021-07-29 | $3.00M derived: sum of 3 quarters · filed 2021-07-29 | $4.62M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $1.30M 10-Q · filed 2021-04-28 | $2.84M derived: sum of 2 quarters · filed 2021-04-28 | $4.46M derived: sum of 3 quarters · filed 2021-04-28 | $5.87M derived: sum of 4 quarters · filed 2021-04-28 |
| 2019-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.16M derived: sum of 2 quarters · filed 2021-02-25 | $4.57M derived: sum of 3 quarters · filed 2021-02-25 | $5.54M 10-K · filed 2021-02-25 |
| 2019-09-30 | $1.62M 10-Q · filed 2020-10-28 | $3.03M derived: sum of 2 quarters · filed 2020-10-28 | $4.00M 10-Q · filed 2020-10-28 | $4.52M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.40M 10-Q · filed 2020-07-29 | $2.38M 10-Q · filed 2020-07-29 | $2.90M derived: sum of 3 quarters · filed 2021-02-25 | $3.27M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $975.00K 10-Q · filed 2020-04-29 | $1.49M derived: sum of 2 quarters · filed 2021-02-25 | $1.86M derived: sum of 3 quarters · filed 2021-02-25 | $2.24M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $889.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.27M derived: sum of 3 quarters · filed 2021-02-25 | $1.66M 10-K · filed 2021-02-25 |
| 2018-09-30 | $370.00K 10-Q · filed 2019-10-30 | $750.00K derived: sum of 2 quarters · filed 2019-10-30 | $1.14M 10-Q · filed 2019-10-30 | $1.53M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $380.00K 10-Q · filed 2019-07-24 | $771.00K 10-Q · filed 2019-07-24 | $1.16M derived: sum of 3 quarters · filed 2020-02-19 | $1.54M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $391.00K 10-Q · filed 2019-05-01 | $784.00K derived: sum of 2 quarters · filed 2020-02-19 | $1.16M derived: sum of 3 quarters · filed 2020-02-19 | $1.47M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $769.00K derived: sum of 2 quarters · filed 2020-02-19 | $1.07M derived: sum of 3 quarters · filed 2020-02-19 | $1.31M 10-K · filed 2020-02-19 |
| 2017-09-30 | $376.00K 10-Q · filed 2018-10-31 | $682.00K derived: sum of 2 quarters · filed 2018-10-31 | $918.00K 10-Q · filed 2018-10-31 | $1.09M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $306.00K 10-Q · filed 2018-07-26 | $542.00K 10-Q · filed 2018-07-26 | $713.00K derived: sum of 3 quarters · filed 2019-02-19 | $875.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $236.00K 10-Q · filed 2018-05-04 | $407.00K derived: sum of 2 quarters · filed 2019-02-19 | $569.00K derived: sum of 3 quarters · filed 2019-02-19 | $726.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $333.00K derived: sum of 2 quarters · filed 2019-02-19 | $490.00K derived: sum of 3 quarters · filed 2019-02-19 | $582.00K 10-K · filed 2019-02-19 |
| 2016-09-30 | $162.00K 10-Q · filed 2017-11-03 | $319.00K derived: sum of 2 quarters · filed 2017-11-03 | $411.00K 10-Q · filed 2017-11-03 | $463.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $157.00K 10-Q · filed 2017-08-08 | $249.00K 10-Q · filed 2017-08-08 | $301.00K derived: sum of 3 quarters · filed 2018-02-23 | $391.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $92.00K 10-Q · filed 2017-05-05 | $144.00K derived: sum of 2 quarters · filed 2018-02-23 | $234.00K derived: sum of 3 quarters · filed 2018-02-23 | $319.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $142.00K derived: sum of 2 quarters · filed 2018-02-23 | $227.00K derived: sum of 3 quarters · filed 2018-02-23 | $343.00K 10-K · filed 2018-02-23 |
| 2015-09-30 | $90.00K 10-Q · filed 2016-11-03 | $175.00K derived: sum of 2 quarters · filed 2016-11-03 | $291.00K 10-Q · filed 2016-11-03 | $408.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $85.00K 10-Q · filed 2016-08-04 | $201.00K 10-Q · filed 2016-08-04 | $318.00K derived: sum of 3 quarters · filed 2017-02-28 | $411.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $116.00K 10-Q · filed 2016-05-05 | $233.00K derived: sum of 2 quarters · filed 2017-02-28 | $326.00K derived: sum of 3 quarters · filed 2017-02-28 | $491.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $210.00K derived: sum of 2 quarters · filed 2017-02-28 | $375.00K derived: sum of 3 quarters · filed 2017-02-28 | $563.00K 10-K · filed 2017-02-28 |
| 2014-09-30 | $93.00K 10-Q · filed 2015-11-05 | $258.00K derived: sum of 2 quarters · filed 2015-11-05 | $446.00K 10-Q · filed 2015-11-05 | $657.00K derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $165.00K 10-Q · filed 2015-08-06 | $353.00K 10-Q · filed 2015-08-06 | $564.00K derived: sum of 3 quarters · filed 2016-02-24 | $756.00K derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $188.00K 10-Q · filed 2015-05-08 | $399.00K derived: sum of 2 quarters · filed 2016-02-24 | $591.00K derived: sum of 3 quarters · filed 2016-02-24 | $781.00K derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $403.00K derived: sum of 2 quarters · filed 2016-02-24 | $593.00K derived: sum of 3 quarters · filed 2016-02-24 | $778.00K 10-K · filed 2016-02-24 |
| 2013-09-30 | $192.00K 10-Q · filed 2014-11-04 | $382.00K derived: sum of 2 quarters · filed 2014-11-04 | $567.00K 10-Q · filed 2014-11-04 | $723.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $190.00K 10-Q · filed 2014-08-07 | $375.00K 10-Q · filed 2014-08-07 | $531.00K derived: sum of 3 quarters · filed 2015-02-27 | $689.00K derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $185.00K 10-Q · filed 2014-05-07 | $341.00K derived: sum of 2 quarters · filed 2015-02-27 | $499.00K derived: sum of 3 quarters · filed 2015-02-27 | |
| 2012-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $314.00K derived: sum of 2 quarters · filed 2015-02-27 | $460.00K 10-K · filed 2015-02-27 | |
| 2012-09-30 | $158.00K 10-Q · filed 2013-11-01 | $304.00K 10-Q · filed 2013-11-01 | ||
| 2011-12-31 | $415.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |